Yersinia pestis vaccine - Introgen Therapeutics/Norwell Inc/University of Texas Medical Branch
Latest Information Update: 27 Jul 2016
At a glance
- Originator Introgen Therapeutics; Norwell Inc; University of Texas Medical Branch
- Class Plague vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Plague
Most Recent Events
- 27 Jul 2016 Discontinued - Preclinical for Plague in USA (Intranasal)